316 related articles for article (PubMed ID: 21199169)
1. New cancer treatment strategy using combination of green tea catechins and anticancer drugs.
Suganuma M; Saha A; Fujiki H
Cancer Sci; 2011 Feb; 102(2):317-23. PubMed ID: 21199169
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effects of multiple treatments, and both DNA and RNA direct bindings on, green tea catechins.
Kuzuhara T; Tanabe A; Sei Y; Yamaguchi K; Suganuma M; Fujiki H
Mol Carcinog; 2007 Aug; 46(8):640-5. PubMed ID: 17440927
[TBL] [Abstract][Full Text] [Related]
3. Synergistic enhancement of anticancer effects on numerous human cancer cell lines treated with the combination of EGCG, other green tea catechins, and anticancer compounds.
Fujiki H; Sueoka E; Watanabe T; Suganuma M
J Cancer Res Clin Oncol; 2015 Sep; 141(9):1511-22. PubMed ID: 25544670
[TBL] [Abstract][Full Text] [Related]
4. Green tea polyphenol stimulates cancer preventive effects of celecoxib in human lung cancer cells by upregulation of GADD153 gene.
Suganuma M; Kurusu M; Suzuki K; Tasaki E; Fujiki H
Int J Cancer; 2006 Jul; 119(1):33-40. PubMed ID: 16463383
[TBL] [Abstract][Full Text] [Related]
5. Green tea: an effective synergist with anticancer drugs for tertiary cancer prevention.
Fujiki H; Suganuma M
Cancer Lett; 2012 Nov; 324(2):119-25. PubMed ID: 22626556
[TBL] [Abstract][Full Text] [Related]
6. Synergistic effects of (--)-epigallocatechin gallate with (--)-epicatechin, sulindac, or tamoxifen on cancer-preventive activity in the human lung cancer cell line PC-9.
Suganuma M; Okabe S; Kai Y; Sueoka N; Sueoka E; Fujiki H
Cancer Res; 1999 Jan; 59(1):44-7. PubMed ID: 9892181
[TBL] [Abstract][Full Text] [Related]
7. New role of (-)-epicatechin in enhancing the induction of growth inhibition and apoptosis in human lung cancer cells by curcumin.
Saha A; Kuzuhara T; Echigo N; Suganuma M; Fujiki H
Cancer Prev Res (Phila); 2010 Aug; 3(8):953-62. PubMed ID: 20606042
[TBL] [Abstract][Full Text] [Related]
8. EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells.
Jung YD; Kim MS; Shin BA; Chay KO; Ahn BW; Liu W; Bucana CD; Gallick GE; Ellis LM
Br J Cancer; 2001 Mar; 84(6):844-50. PubMed ID: 11259102
[TBL] [Abstract][Full Text] [Related]
9. Identification of epigallocatechin-3-gallate in green tea polyphenols as a potent inducer of p53-dependent apoptosis in the human lung cancer cell line A549.
Yamauchi R; Sasaki K; Yoshida K
Toxicol In Vitro; 2009 Aug; 23(5):834-9. PubMed ID: 19406223
[TBL] [Abstract][Full Text] [Related]
10. Prooxidant property of green tea polyphenols epicatechin and epigallocatechin-3-gallate: implications for anticancer properties.
Azam S; Hadi N; Khan NU; Hadi SM
Toxicol In Vitro; 2004 Oct; 18(5):555-61. PubMed ID: 15251172
[TBL] [Abstract][Full Text] [Related]
11. Cancer chemoprevention with green tea catechins by targeting receptor tyrosine kinases.
Shimizu M; Adachi S; Masuda M; Kozawa O; Moriwaki H
Mol Nutr Food Res; 2011 Jun; 55(6):832-43. PubMed ID: 21538846
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of histone deacetylase 4, -5 and -6 as a mechanism of synergistic enhancement of apoptosis in human lung cancer cells treated with the combination of a synthetic retinoid, Am80 and green tea catechin.
Oya Y; Mondal A; Rawangkan A; Umsumarng S; Iida K; Watanabe T; Kanno M; Suzuki K; Li Z; Kagechika H; Shudo K; Fujiki H; Suganuma M
J Nutr Biochem; 2017 Apr; 42():7-16. PubMed ID: 28103535
[TBL] [Abstract][Full Text] [Related]
13. Green tea polyphenol (-)-epigallocatechin-3-gallate inhibits cyclooxygenase-2 expression in colon carcinogenesis.
Peng G; Dixon DA; Muga SJ; Smith TJ; Wargovich MJ
Mol Carcinog; 2006 May; 45(5):309-19. PubMed ID: 16508969
[TBL] [Abstract][Full Text] [Related]
14. Anticancer effects of (-)-epigallocatechin-3-gallate on ovarian carcinoma cell lines.
Huh SW; Bae SM; Kim YW; Lee JM; Namkoong SE; Lee IP; Kim SH; Kim CK; Ahn WS
Gynecol Oncol; 2004 Sep; 94(3):760-8. PubMed ID: 15350370
[TBL] [Abstract][Full Text] [Related]
15. Lung cancer prevention with (-)-epigallocatechin gallate using monitoring by heterogeneous nuclear ribonucleoprotein B1.
Fujimoto N; Sueoka N; Sueoka E; Okabe S; Suganuma M; Harada M; Fujiki H
Int J Oncol; 2002 Jun; 20(6):1233-9. PubMed ID: 12012004
[TBL] [Abstract][Full Text] [Related]
16. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.
Thangapazham RL; Singh AK; Sharma A; Warren J; Gaddipati JP; Maheshwari RK
Cancer Lett; 2007 Jan; 245(1-2):232-41. PubMed ID: 16519995
[TBL] [Abstract][Full Text] [Related]
17. Green tea catechins augment the antitumor activity of doxorubicin in an in vivo mouse model for chemoresistant liver cancer.
Liang G; Tang A; Lin X; Li L; Zhang S; Huang Z; Tang H; Li QQ
Int J Oncol; 2010 Jul; 37(1):111-23. PubMed ID: 20514403
[TBL] [Abstract][Full Text] [Related]
18. Cell cycle dysregulation by green tea polyphenol epigallocatechin-3-gallate.
Ahmad N; Cheng P; Mukhtar H
Biochem Biophys Res Commun; 2000 Aug; 275(2):328-34. PubMed ID: 10964666
[TBL] [Abstract][Full Text] [Related]
19. Combined inhibitory effects of green tea polyphenols and selective cyclooxygenase-2 inhibitors on the growth of human prostate cancer cells both in vitro and in vivo.
Adhami VM; Malik A; Zaman N; Sarfaraz S; Siddiqui IA; Syed DN; Afaq F; Pasha FS; Saleem M; Mukhtar H
Clin Cancer Res; 2007 Mar; 13(5):1611-9. PubMed ID: 17332308
[TBL] [Abstract][Full Text] [Related]
20. Green tea polyphenol epigallocatechin-3-gallate (EGCG) as adjuvant in cancer therapy.
Lecumberri E; Dupertuis YM; Miralbell R; Pichard C
Clin Nutr; 2013 Dec; 32(6):894-903. PubMed ID: 23582951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
